Welcome to Gender Analysis

Gender Analysis is a web series launched in 2014 exploring transgender science and life experiences in depth, and revealing the many insights to be found at their intersection. We take a closer look at fields such as sociology, public health, psychiatry, cognitive science, and more, weaving these diverse perspectives into a deeper understanding of gender-related phenomena. Gender Analysis goes beyond the 101s to educate both trans and cis viewers on some of the most fascinating dimensions of our lives – and the pressing issues we face in society.

Support Gender Analysis on Patreon

New episodes of Gender Analysis are published several times a month and are backed by our generous supporters on Patreon. Want to learn more? Check out our instant index for a quick introduction to the wide range of topics we cover:

Curious about…?

Gender dysphoria Self-discovery
How hormones work Bathroom bills
Finding a doctor Treatments for trans youth
Passing Sexuality
Transness and autism Paul McHugh
Regret and detransition Sex chromosomes
Posted in Gender Analysis | Leave a comment

Florida Department of Health Guidance Against Transgender Youth Healthcare Contains False Statements and Misrepresentations and Should Not Be Used by Anyone (part 4)

FLDOH’s anti-trans guidance cites several sources which actually support access to gender-affirming care

Previously: The FLDOH guide to parenting: Ignore a child’s issues, and just hope it all goes away

The Florida Department of Health’s 2022 anti-trans guidance declares:

One review concludes that “hormonal treatments for transgender adolescents can achieve their intended physical effects, but evidence regarding their psychosocial and cognitive impact is generally lacking.” . . . Social gender transition should not be a treatment option for children or adolescents. Anyone under 18 should not be prescribed puberty blockers or hormone therapy.

This obnoxious formatting implies that the linked resources support these positions. That is false: most of these sources clearly contradict the FLDOH guidance and do not recommend against social transition, puberty blockers, or hormone therapy for those under 18. Continue reading

Posted in Gender dysphoria, Health care, News, Outcomes of transition, Politics and law, Replies, Trans youth, Transgender medicine, Transphobia and prejudice | Tagged , , , , , , , | Leave a comment

Florida Department of Health Guidance Against Transgender Youth Healthcare Contains False Statements and Misrepresentations and Should Not Be Used by Anyone (part 3)

The FLDOH guide to parenting: Ignore a child’s issues, and just hope it all goes away

Previously: FLDOH anti-trans guidance attacks “low-quality evidence” for gender-affirming care, citing low-quality evidence for conversion therapy

The Florida Department of Health states in their 2022 guidance:

Based on the currently available evidence, “encouraging mastectomy, ovariectomy, uterine extirpation, penile disablement, tracheal shave, the prescription of hormones which are out of line with the genetic make-up of the child, or puberty blockers, are all clinical practices which run an unacceptably high risk of doing harm.”

In this bullet point, FLDOH cites a brief article by psychoanalytic psychologist David Schwartz (2021) outlining his personal history in clinical practice and his opinions on gender-affirming care. Like Hruz (2019), this is not any kind of systematic review of evidence. Large swathes of Schwartz’s assessment of the “currently available evidence” are merely his own assertions without any supporting references, or the most cursory sprinkling of tangentially relevant sources, and none of it constitutes an adequate summary of that evidence. Continue reading

Posted in Gender dysphoria, Health care, News, Outcomes of transition, Politics and law, Replies, Trans youth, Transgender medicine, Transphobia and prejudice | Tagged , , , , , , , | Leave a comment

Florida Department of Health Guidance Against Transgender Youth Healthcare Contains False Statements and Misrepresentations and Should Not Be Used by Anyone (part 2)

FLDOH anti-trans guidance attacks “low-quality evidence” for gender-affirming care, citing low-quality evidence for conversion therapy

Previously: FLDOH guidance against social transition, puberty blockers, or HRT for minors is not supported by cited documents from CMS, Sweden, Finland, England, or France

In their 2022 document “Treatment of Gender Dysphoria for Children and Adolescents”, the Florida Department of Health writes:

Systematic reviews on hormonal treatment for young people show a trend of low-quality evidence, small sample sizes, and medium to high risk of bias.

Hruz (2019) is not a systematic review

The linked “systematic reviews” is actually one four-page article by Paul W. Hruz (2019) in the Catholic Medical Association’s journal The Linacre Quarterly, and it is not a systematic review. It broadly encompasses the spectrum of gender-affirming care across all ages and does not specifically focus on “hormonal treatment for young people”. The journal has published it as a “research article”, and it is an unorganized continuous wall of text:

It does not possess any of the expected features of a systematic review, such as a specific research question or discussion of search criteria for inclusion of studies (Robertson-Malt, 2014). The FLDOH has erred in labeling this a “systematic review”. Continue reading

Posted in Gender dysphoria, Health care, News, Outcomes of transition, Politics and law, Replies, Trans youth, Transgender medicine, Transphobia and prejudice | Tagged , , , , , , , | Leave a comment

Florida Department of Health Guidance Against Transgender Youth Healthcare Contains False Statements and Misrepresentations and Should Not Be Used by Anyone (part 1)

FLDOH guidance against social transition, puberty blockers, or HRT for minors is not supported by cited documents from CMS, Sweden, Finland, England, or France

On April 20, 2022, the Florida Department of Health published three nonbinding documents containing sweeping and inaccurate claims about transgender youth and gender-affirming care: the press release “Florida Department of Health Releases Guidance on Treatment of Gender Dysphoria for Children and Adolescents”; the PDF “Treatment of Gender Dysphoria for Children and Adolescents”; and the PDF “Treatment of Gender Dysphoria for Children and Adolescents – Fact Check”. These documents are sloppily written, typically citing either low-quality opinion sources or selectively quoting from sources that clearly contradict the position FLDOH is attempting to support, and at times referring to documents that are not about even about children and adolescents.

The FLDOH misrepresents brief opinion pieces from individual authors in Catholic and psychoanalytic journals as constituting reliable literature reviews of existing knowledge on transgender healthcare and development. FLDOH makes invalid assumptions about desistance of childhood gender dysphoria at adolescence, misrepresents its clinical relevance, and then offers advice far beyond what this evidence supports. And the FLDOH simply lies about numerous national health authorities in the United States and abroad agreeing with the department’s entirely unsupported anti-trans guidance.

These documents represent another disgraceful failure of the FLDOH under the DeSantis administration to fulfill its basic mission of providing reliable, high-quality health information to all citizens of Florida. The fact is that everyone in the state, cis or trans, whether they care about transgender issues or not at all, is now being subjected to another insulting disservice from a department that is already bleeding credibility in the COVID-19 crisis, particularly under the leadership of state surgeon general Joseph A. Ladapo. What they’ve passed off as guidance here is nothing but an embarrassment, and its fatal flaws will be visible to anyone who bothers to follow its sources. Those sources are examined here. Continue reading

Posted in Gender dysphoria, Health care, News, Outcomes of transition, Politics and law, Replies, Trans youth, Transgender medicine, Transphobia and prejudice | Tagged , , , , , , , | 1 Comment

Abigail Shrier and surgeon Marci Bowers falsely claimed trans girls on puberty blockers lack sexual response after vaginoplasty

Last October, anti-trans activist Abigail Shrier was platformed on Bari Weiss’s Substack to discuss – what else? – being silenced. In “Top Trans Doctors Blow the Whistle on ‘Sloppy’ Care”, Shrier opens:

For nearly a decade, the vanguard of the transgender-rights movement — doctors, activists, celebrities and transgender influencers — has defined the boundaries of the new orthodoxy surrounding transgender medical care: What’s true, what’s false, which questions can and cannot be asked.

As a Littman-certified “transgender influencer”, I decided to spend some time asking exactly those questions raised in her article, particularly this ominous claim:

And they never said anything about the distinct possibility that blocking puberty, coupled with cross-sex hormones, could inhibit a normal sex life.

Shrier’s assertion of sexual dysfunction is a fusion of two claims. One questions the outcomes of alternative vaginoplasty techniques necessary for some trans girls who may have very little genital tissue due to early use of puberty blockers. This known issue was broadly misused as a right-wing talking point that began circulating several years ago – long after equally effective surgeries were already in widespread use. The other is an apparently novel claim by Dr. Marci Bowers, a trans woman and vaginoplasty surgeon, that some experience of sexual stimulation or orgasm is necessary before vaginoplasty in order to access any meaningful sexual arousal after surgery. In her telling, early use of puberty blockers at Tanner stages 2 or 3 of a youth’s natal puberty could leave them sexually “naïve” and never motivated to seek out any sexual stimulation or derive enjoyment from this, an issue she says is not being acknowledged by other transition care providers.

But extensive data does exist on these questions. These and other relevant issues have been studied at length in clinical settings, and major transgender care centers have continued to publish their detailed findings in this patient group. What we know about the outcomes of youth who receive these treatments does not at all reflect the claims of Shrier and Bowers. Let’s directly refute the central point. Continue reading

Posted in Hoaxes, Outcomes of transition, Replies, Safety data, Sexuality, Surgery, Trans youth, Transfeminine, Transphobia and prejudice | Tagged , , , , , | Leave a comment